Article
Author(s):
In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective.
In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective. "There is no one-size-fits-all measure of diabetes quality or glycemic care," said Dr Herman. Dr Herman also discussed his viewpoint as a clinical endocrinologist diabetologist. "So patients who are remarkably likely to have targets I think the targets were appropriately modified based on risk of hypoglycemia," said Herman. "I do have general concern that maybe the targets are even too low based on the evidence."
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
How Can Employers Leverage the DPP to Improve Diabetes Rates?
FDA Expands Omnipod 5 AID System Label to Treat Type 2 Diabetes